Evidence map›Paper›PMID 34644438›Full record

ArticleXenotransplantation2021

Histopathology of pig kidney grafts with/without expression of the carbohydrate Neu5Gc in immunosuppressed baboons.

Jeremy B Foote, Abhijit Jagdale, Takayuki Yamamoto, Hidetaka Hara, Mohamed H Bikhet, Henk-Jan Schuurman, Huy Q Nguyen, Mohamed Ezzelarab, David Ayares, Douglas J Anderson and 4 more

Open access · greenAbstract read
In one paragraph

Article in Xenotransplantation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. The Evolution of Immunosuppressive Therapy in Pig-to-Nonhuman Primate Organ Transplantation.Transplant international : official journal of the European Society for Organ Transplantation · 2024
    Review
  2. Review
  3. Review
  4. Milestones on the path to clinical pig organ xenotransplantation.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2023
    Review
  5. Review
  6. Developments in kidney xenotransplantation.Frontiers in immunology · 2023
    Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Jeremy B FooteDepartment of Microbiology and Animal Resources Program, University of Alabama at Birmingham, Birmingham, Alabama, USA.ORCID 0000-0002-6621-6096
Abhijit JagdaleDepartment of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Takayuki YamamotoDepartment of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Hidetaka HaraDepartment of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Mohamed H BikhetDepartment of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Henk-Jan SchuurmanSchubiomed Consultancy, Utrecht, The Netherlands.
Huy Q NguyenDepartment of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Mohamed EzzelarabThomas E. Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.ORCID 0000-0002-3919-5250
David AyaresRevivicor, Blacksburg, Virginia, USA.
Douglas J AndersonDepartment of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Huma FatimaDepartment of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Devin E EckhoffDepartment of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.
David K C CooperDepartment of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.ORCID 0000-0002-8899-9431
Hayato IwaseDepartment of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.
University of Alabama at Birmingham · US21c Consultancy (United Kingdom) · GBBeth Israel Deaconess Medical Center · USUniversity of Pittsburgh · US

Funding

Prolonging life-supported pig kidney and heart graft survival in baboons by suppressing inflammationU19AI090959 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI COOPER, DAVID KC · 2010 to 2024
$26.3M
Nonhuman Primate Reagent ResourceU24AI126683 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Diogo Magnani · 2016 to 2026
$20.1M
Specific Pathogen Free Baboon Research Resource (SPFBRR) - Bridge Funding Administrative SupplementP40OD024628 · OD · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WILLIAM D HOPKINS · 2017 to 2026
$15.7M
Resource for Nonhuman Primate Cell Depleting AntibodiesR24OD010976 · OD · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI ENGELMAN, KATHLEEN, MAGNANI, DIOGO · 2012 to 2019
$4.7M
NIAID NIH HHS U19 AI090959NIAID NIH HHS U24 AI126683NIH HHS P40 OD024628NIH HHS R24 OD010976
6 · The paper itself

Abstract

introductionPigs deficient in three glycosyltransferase enzymes (triple-knockout [TKO] pigs, that is, not expressing the three known carbohydrate xenoantigens) and expressing 'protective' human transgenes are considered a likely source of organs for transplantation into human recipients. Some human sera have no or minimal natural antibody binding to red blood cells (RBCs) and peripheral blood mononuclear cells (PBMCs) from TKO pigs. However, all Old World monkeys exhibit natural antibody binding to TKO pig cells. The xenoantigen targets of Old World monkey natural antibodies are postulated to be carbohydrate moieties exposed when the expression of the carbohydrate N-glycolylneuraminic acid (Neu5Gc) is deleted. The aim of this study was to compare the survival in baboons and histopathology of renal grafts from pigs that either (a) expressed Neu5Gc (GTKO pigs; Group 1) or (b) did not express Neu5Gc (GTKO/CMAHKO [DKO] or TKO pigs; Group 2).

methodsLife-supporting renal transplants were carried out using GTKO (n = 5) or DKO/TKO (n = 5) pig kidneys under an anti-CD40mAb-based immunosuppressive regimen.

resultsGroup 1 baboons survived longer than Group 2 baboons (median 237 vs. 35 days; mean 196 vs. 57 days; p < 0.07) and exhibited histopathological features of antibody-mediated rejection in only two kidneys. Group 2 exhibited histopathological features of antibody-mediated rejection in all five grafts, with IgM and IgG binding to renal interstitial arteries and peritubular capillaries. Rejection-free survival was significantly longer in Group 1 (p < 0.05).

conclusionsThe absence of expression of Neu5Gc on pig kidney grafts is associated with increased binding of baboon antibodies to pig endothelium and reduced graft survival.

Indexed as

KidneyLeukocytes, MononuclearAnimalsAnimals, Genetically ModifiedCarbohydratesGraft RejectionPapioSwineTransplantation, HeterologousCarbohydratesbaboongenetically-engineeredhistopathologykidneyNeu5GcN-glycolylneuraminic acidpigxenotransplantation

Identifiers

PMID34644438
PMCPMC9157534
OpenAlexW3206107651

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.